Rathbones Group PLC Cara Therapeutics, Inc. Transaction History
Rathbones Group PLC
- $19 Billion
- Q3 2024
A detailed history of Rathbones Group PLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 20,164 shares of CARA stock, worth $6,654. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,164
Previous 20,164
-0.0%
Holding current value
$6,654
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CARA
# of Institutions
76Shares Held
14.4MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.25MShares$742,1400.0% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$561,6960.06% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$513,5620.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.11MShares$367,3040.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.11MShares$365,9470.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $17.7M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...